Course Description

The Research Misconduct Prevention Module is focused primarily on federal research misconduct requirements for Public Health Service-funded research, the group of Health and Human Services Agencies, e.g. NIH, CDC and FDA, which provide the majority of Mass General Brigham federal research funding. In addition to definitions and regulatory and policy requirements, the Module also identifies what a PI should do when a research misconduct allegation is brought to his/her attention and best practices for fostering a culture of compliance and integrity within your labs and research groups. From both a regulatory and ethical perspective, as PIs we are responsible for the scientific integrity of research produced under our leadership and for instilling research ethics in our students and fellows and the junior investigators.

This activity consists of two 15-minute sections. To complete each section, you must view the 2 different presentations (located on the 'Archived Webinar' tab) and complete the post-test and evaluation.

Learning Objectives

Upon completion of this activity, participants will be able to:

1. Provide overview of federal, sponsor and Mass General Brigham financial policies
2. Introduce different federal funding instruments and their requirements
     a. Contracts
     b. Grants
     c. Cooperative Agreements
     d. Subcontracts
3. Provide overview of federal cost principles
     a. Reasonable
     b. Allowable
     c. Allocable
     d. Consistently applied
4. Review Principal Investigator financial oversight responsibilities
5. Review requirements of selected cost items

Target Audience

This activity is intended for all Mass General Brigham Principal Investigators with active grants and contracts and Sundry accounts.

This activity is free of charge. To complete each section, you must view the 2 different presentations (located on the 'Archived Webinar' tab) and complete the post-test and evaluation.

For questions regarding registration, please contact Mass General Brigham Office of Continuing Professional Development at [email protected].

For questions regarding the Research Education Series, please contact Mass General Brigham Research Compliance Office at [email protected].

Faculty

Paul Anderson, MD, PhD
Chief Academic Officer, Senior Vice President of Research
K. Frank Austen Professor of Medicine, Harvard Medical School

Dennis Brown, PhD
Director, Massachusetts General Hospital Program in Membrane Biology;
Director, Massachusetts General Hospital Office for Research Career Development;
Professor of Medicine, Harvard Medical School

Scott Lukas, PhD
Director, McLean Imaging Center;
Director, Behavioral Psychopharmacology Research Laboratory
Professor of Psychiatry, Harvard Medical School

Anne Klibanski, MD
Laurie Carrol Guthart Professor of Medicine, Harvard Medical School
President and CEO, Mass General Brigham 

Mary Mitchell
Mass General Brigham Chief Research Compliance Officer

Allison Moriarty
Brigham and Women's Hospital Vice President, Research Administration and Compliance

This enduring material will be available on-demand for year.

Release Date: October 22, 2015
Review Date: 
Expiration Date: August 31, 2022
Duration: 30 minutes total

Accreditation

Mass General Brigham is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Mass General Brigham designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosure Statements

In accord with the disclosure policy of Mass General Brigham  as well as guidelines of the Accreditation Council for Continuing Medical Education (ACCME), planners, speakers and anyone who may have an influence on the content of the activity have been asked to disclose any relationship they or their spouse/partner have to companies producing pharmaceuticals, medical equipment, devices, etc. that may be germane to the content of their presentation. Such disclosure is not intended to suggest or condone bias, but provides participants with information that might be of potential importance to their evaluation of a given presentation.

RESOLUTION OF CONFLICTS OF INTEREST (COI)
Mass General Brigham  has implemented a process to resolve potential COIs for this CME activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public.

The following planners and/or their spouse/partner have reported  no relevant financial relationship with a commercial interest:
Chris Clark 
Robert Damiano
Mary Mitchell
Allison Moriarty
Danielle Morin
Beth Watters

The following planner and/or their spouse/partner has reported a relevant financial relationship with a commercial interest:
Anne Klibanski, MD
Investigator: Ipsen, Novartis, Rhythm Pharmaceuticals

The following reviewer and/or their spouse/partner have reported  no relevant financial relationship with a commercial interest
Mary Mitchell 

The following speakers and/or their spouse/partner have reported no relevant financial relationship with a commercial interest:
Mary Mitchell
Allison Moriarty

The following speakers and/or their spouse/partner have reported a relevant financial relationship with a commercial interest:
Paul Anderson, MD, PhD
Employee (spouse): GlaxoSmithKline

Dennis Brown, PhD
Inventor: Exosome Diagnostics

Anne Klibanski, MD
Investigator: Ipsen, Novartis, Rhythm Pharmceuticals

Scott Lukas, PhD
Expert Witness: Various law firms

This internet-based CME activity is best experienced Microsoft Internet Explorer 9.0 or later, Mozilla Firefox 13 or later, Chrome 16 or later, Safari (version 5 or later)

Hardware/Software Specifications: 
This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, and Microsoft PowerPoint.

Optimal System Configuration: 
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 13+, Internet Explorer 9.0+, Safari 13+, or Google Chrome 16+
Operating System: Windows Vista,7,8 or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher

Minimum Requirements: 
Windows PC: 
Intel Pentium 4 or equivalent with 2.33 GHz processor; Windows XP; 512 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 3+, Internet Explorer 7.0+, Safari 4+, Google Chrome, or Opera
Macintosh: 
Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster;RAM: 128MB or more; Video Card: at least 128MB of video memory; Sound Card: at least 16bit

Provided by:

Mass General Brigham